Literature DB >> 12662187

Course of migraine during pregnancy and postpartum: a prospective study.

G Sances1, F Granella, R E Nappi, A Fignon, N Ghiotto, F Polatti, G Nappi.   

Abstract

The aim of this study was to investigate prospectively the course of migraine during pregnancy and postpartum. Of all the pregnant women consecutively attending an obstetrics and gynaecology department for a routine first-trimester antenatal check-up, 49 migraine sufferers--two were affected by migraine with aura (MA) and 47 by migraine without aura (MO)--who had experienced at least one attack during the 3 months preceding pregnancy were identified, enrolled in the study and given a headache diary. Subsequent examinations were performed at the end of the second and third trimesters and 1 month after delivery. Migraine was seen to improve in 46.8% of the 47 MO sufferers during the first trimester, in 83.0% during the second and in 87.2% during the third, while complete remission was attained by 10.6%, 53.2%, and 78.7% of the women, respectively. Migraine recurred during the first week after childbirth in 34.0% of the women and during the first month in 55.3%. Certain risk factors for lack of improvement of migraine during pregnancy were identified: the presence of menstrually related migraine before pregnancy was associated with a lack of headache improvement in the first and third trimesters, while second-trimester hyperemesis, and a pathological pregnancy course were associated with a lack of headache improvement in the second trimester. Breast feeding seemed to protect from migraine recurrence during postpartum.

Entities:  

Mesh:

Year:  2003        PMID: 12662187     DOI: 10.1046/j.1468-2982.2003.00480.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  56 in total

1.  Lifetime prevalence and correlates of migraine among women in a pacific northwest pregnancy cohort study.

Authors:  Ihunnaya O Frederick; Chunfang Qiu; Daniel A Enquobahrie; Sheena K Aurora; B Lee Peterlin; Bizu Gelaye; Michelle A Williams
Journal:  Headache       Date:  2013-08-28       Impact factor: 5.887

Review 2.  Migraine during pregnancy: options for therapy.

Authors:  Anthony W Fox; Merle L Diamond; Egilius L H Spierings
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Acute neurological issues in pregnancy and the peripartum.

Authors:  Catherine M Hosley; Louise D McCullough
Journal:  Neurohospitalist       Date:  2011-04

Review 4.  Migraine in pregnancy.

Authors:  Peter J Goadsby; Jay Goldberg; Stephen D Silberstein
Journal:  BMJ       Date:  2008-06-28

Review 5.  [Alternatives to beta blockers in preventive migraine treatment].

Authors:  S Evers
Journal:  Nervenarzt       Date:  2008-10       Impact factor: 1.214

6.  Migraine and subsequent risk of breast cancer: a prospective cohort study.

Authors:  Anke C Winter; Kathryn M Rexrode; I-Min Lee; Julie E Buring; Rulla M Tamimi; Tobias Kurth
Journal:  Cancer Causes Control       Date:  2012-11-10       Impact factor: 2.506

7.  Migraine in postmenopausal women and the risk of invasive breast cancer.

Authors:  Robert W Mathes; Kathleen E Malone; Janet R Daling; Scott Davis; Sylvia M Lucas; Peggy L Porter; Christopher I Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

Review 8.  Estrogen, migraine, and vascular risk.

Authors:  Gianni Allais; Giulia Chiarle; Silvia Sinigaglia; Gisella Airola; Paola Schiapparelli; Chiara Benedetto
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

9.  Sleep duration, vital exhaustion and perceived stress among pregnant migraineurs and non-migraineurs.

Authors:  Michelle A Williams; Sheena K Aurora; Ihunnaya O Frederick; Chunfang Qiu; Bizu Gelaye; Swee May Cripe
Journal:  BMC Pregnancy Childbirth       Date:  2010-11-03       Impact factor: 3.007

10.  Risk of placental abruption in relation to migraines and headaches.

Authors:  Sixto E Sanchez; Michelle A Williams; Percy N Pacora; Cande V Ananth; Chungfang Qiu; Sheena K Aurora; Tanya K Sorensen
Journal:  BMC Womens Health       Date:  2010-10-26       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.